Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation: The APAF-CSP All-cause Mortality and Quality of Life Trial

NCT07604727 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT07604727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07604727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation: The APAF-CSP All-cause Mortality and Quality of Life Trial
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
June 30, 2030
Enrollment
292 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), cardiac pacing, heart failure